Arbutus Biopharma Corp Stock Probability of Future Stock Price Finishing Over 10.08
ABUS Stock | USD 3.64 0.12 3.19% |
Arbutus |
Arbutus Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arbutus Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arbutus Biopharma Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Arbutus Biopharma generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 18.14 M. Net Loss for the year was (72.85 M) with loss before overhead, payroll, taxes, and interest of (45.39 M). | |
Arbutus Biopharma Corp currently holds about 150.2 M in cash with (85.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
Arbutus Biopharma has a very weak financial position based on the latest SEC disclosures | |
Roughly 22.0% of the company shares are held by company insiders |
Arbutus Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arbutus Stock often depends not only on the future outlook of the current and potential Arbutus Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arbutus Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 166 M | |
Cash And Short Term Investments | 126 M |
Arbutus Biopharma Technical Analysis
Arbutus Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Arbutus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arbutus Biopharma Corp. In general, you should focus on analyzing Arbutus Stock price patterns and their correlations with different microeconomic environments and drivers.
Arbutus Biopharma Predictive Forecast Models
Arbutus Biopharma's time-series forecasting models is one of many Arbutus Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arbutus Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arbutus Biopharma Corp
Checking the ongoing alerts about Arbutus Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arbutus Biopharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Arbutus Biopharma generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 18.14 M. Net Loss for the year was (72.85 M) with loss before overhead, payroll, taxes, and interest of (45.39 M). | |
Arbutus Biopharma Corp currently holds about 150.2 M in cash with (85.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
Arbutus Biopharma has a very weak financial position based on the latest SEC disclosures | |
Roughly 22.0% of the company shares are held by company insiders |
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.